Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

[1]  W. Mckenna,et al.  Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. , 1995, Heart.

[2]  J. Meakins,et al.  The delayed hypersensitivity response and host resistance in surgical patients. 20 years later. , 1995 .

[3]  B. Bonavida,et al.  Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. , 1995, Neuroimmunomodulation.

[4]  A. Maisel.  Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function. , 1994, Circulation.

[5]  J. Palmblad,et al.  Low levels of essential fatty acids are related to impaired delayed skin hypersensitivity in malnourished chronically ill elderly people , 1994, European journal of clinical investigation.

[6]  M. Piedmonte,et al.  Anergic response to delayed hypersensitivity skin testing. A predictor of early mortality in heart transplant recipients. , 1993, Chest.

[7]  H. Rasmussen,et al.  Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. , 1993, The Journal of clinical investigation.

[8]  M. de Carli,et al.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.

[9]  J. Goodwin,et al.  Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. , 1990, Journal of gerontology.

[10]  L. Stevenson,et al.  Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. , 1989, The American journal of cardiology.

[11]  P. Weiner,et al.  Decline in mitogen induced proliferation of lymphocytes with increasing age. , 1987, Clinical and experimental immunology.

[12]  I. Mackay,et al.  Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. , 1985, Clinical immunology and immunopathology.

[13]  B. Lesourd,et al.  Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A. , 1984, Annals of allergy.

[14]  I. Mackay,et al.  Ageing, immune response, and mortality. , 1974, Lancet.